AR219561A1 - PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 1-PIPERIDINE-6,7-DIALCOXI-FTALAZINE USEFUL AS THERAPEUTIC AGENTS - Google Patents

PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 1-PIPERIDINE-6,7-DIALCOXI-FTALAZINE USEFUL AS THERAPEUTIC AGENTS

Info

Publication number
AR219561A1
AR219561A1 AR274311A AR27431178A AR219561A1 AR 219561 A1 AR219561 A1 AR 219561A1 AR 274311 A AR274311 A AR 274311A AR 27431178 A AR27431178 A AR 27431178A AR 219561 A1 AR219561 A1 AR 219561A1
Authority
AR
Argentina
Prior art keywords
ftalazine
dialcoxi
piperidine
procedure
useful
Prior art date
Application number
AR274311A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR219561A1 publication Critical patent/AR219561A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
AR274311A 1977-11-03 1978-11-10 PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 1-PIPERIDINE-6,7-DIALCOXI-FTALAZINE USEFUL AS THERAPEUTIC AGENTS AR219561A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4567077 1977-11-03

Publications (1)

Publication Number Publication Date
AR219561A1 true AR219561A1 (en) 1980-08-29

Family

ID=10438118

Family Applications (3)

Application Number Title Priority Date Filing Date
AR274311A AR219561A1 (en) 1977-11-03 1978-11-10 PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 1-PIPERIDINE-6,7-DIALCOXI-FTALAZINE USEFUL AS THERAPEUTIC AGENTS
AR278749A AR217577A1 (en) 1977-11-03 1979-11-02 PROCEDURE FOR THE PREPARATION OF 6,7-DIALCOXI-1-PIPERIDINE PHTHALAZINES USEFUL AS THERAPEUTIC AGENTS
AR278750A AR217578A1 (en) 1977-11-03 1979-11-02 PROCEDURE FOR THE PREPARATION OF 6,7-DIALCOXI-1-PIPERIDINE PHTHALAZINES, USEFUL AS THERAPEUTIC AGENTS

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR278749A AR217577A1 (en) 1977-11-03 1979-11-02 PROCEDURE FOR THE PREPARATION OF 6,7-DIALCOXI-1-PIPERIDINE PHTHALAZINES USEFUL AS THERAPEUTIC AGENTS
AR278750A AR217578A1 (en) 1977-11-03 1979-11-02 PROCEDURE FOR THE PREPARATION OF 6,7-DIALCOXI-1-PIPERIDINE PHTHALAZINES, USEFUL AS THERAPEUTIC AGENTS

Country Status (20)

Country Link
JP (1) JPS5498783A (en)
AR (3) AR219561A1 (en)
AT (1) AT365184B (en)
AU (1) AU507007B2 (en)
BE (1) BE871770A (en)
CA (1) CA1114379A (en)
DE (1) DE2847621A1 (en)
DK (1) DK487978A (en)
ES (5) ES474764A0 (en)
FI (1) FI783326A (en)
FR (1) FR2407927A1 (en)
IE (1) IE47481B1 (en)
IL (1) IL55844A (en)
IT (1) IT1101279B (en)
LU (1) LU80458A1 (en)
NL (1) NL7810864A (en)
PH (1) PH14659A (en)
PT (1) PT68734A (en)
SE (1) SE7811322L (en)
YU (3) YU253678A (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6215356U (en) * 1985-07-15 1987-01-29
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CA2523566A1 (en) * 2003-05-07 2004-11-18 Actelion Pharmaceuticals Ltd. Piperazine-alkyl-ureido derivatives
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514671A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists and uses thereof
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
KR102272746B1 (en) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 Ultra-pure agonists of guanylate cyclase c, method of making and using same
KR102456567B1 (en) 2013-08-09 2022-10-19 알데릭스, 인코포레이티드 Compounds and methods for inhibiting phosphate transport
CN114340631A (en) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 Combination for reducing serum phosphate in a patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
FI783326A (en) 1979-05-04
ES479994A1 (en) 1980-08-16
ES479992A1 (en) 1980-09-01
IT1101279B (en) 1985-09-28
AR217577A1 (en) 1980-03-31
JPS5538352B2 (en) 1980-10-03
IT7829369A0 (en) 1978-11-02
AU507007B2 (en) 1980-01-31
BE871770A (en) 1979-05-03
JPS5498783A (en) 1979-08-03
PT68734A (en) 1978-12-01
FR2407927A1 (en) 1979-06-01
PH14659A (en) 1981-10-20
ES479991A1 (en) 1980-08-16
IL55844A0 (en) 1979-01-31
AT365184B (en) 1981-12-28
ES474764A0 (en) 1980-08-16
AR217578A1 (en) 1980-03-31
ATA783978A (en) 1981-05-15
ES479993A1 (en) 1980-08-16
YU211682A (en) 1983-02-28
YU253678A (en) 1983-02-28
AU4127678A (en) 1979-05-17
IE47481B1 (en) 1984-04-04
SE7811322L (en) 1979-05-04
CA1114379A (en) 1981-12-15
LU80458A1 (en) 1980-05-07
FR2407927B1 (en) 1982-07-16
NL7810864A (en) 1979-05-07
DK487978A (en) 1979-05-04
DE2847621A1 (en) 1979-05-17
IE782166L (en) 1979-05-03
YU211582A (en) 1983-02-28
IL55844A (en) 1982-05-31

Similar Documents

Publication Publication Date Title
MX5950E (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF PIRROLIDIN-2-ONA
MX5527E (en) PROCEDURE FOR THE PREPARATION OF CARBOESTIRILE DERIVATIVES
AR220004A1 (en) PROCEDURE FOR THE PREPARATION OF 4,4-DIMETHYL-2-IMIDAZOLIDINONE DERIVATIVES
MX4988E (en) PROCEDURE FOR THE PREPARATION OF PYRROLIDINIC DERIVATIVES
MX5934E (en) PROCEDURE FOR THE PREPARATION OF 1-SUBSTITUTED-4,5-DIARIL-2- (TIOSUBSTITUTED) IMIDAZOLES
AR221851A1 (en) PROCEDURE FOR THE PREPARATION OF 4-PIPERIDINE-6,7-DIALCOXY-QUINAZOLINE DERIVATIVES
AR219561A1 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 1-PIPERIDINE-6,7-DIALCOXI-FTALAZINE USEFUL AS THERAPEUTIC AGENTS
AR225727A1 (en) PROCEDURE TO OBTAIN NEW DERIVATIVES OF INTERFENNILEN-8-AZA-9-DIOXOTIA-11,12-SECO-PROSTAGLANDINA
MX6053E (en) MICROBIOLOGICAL PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF SESCHITERPEN
MX5479E (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 1-OXADETIACEFALOSPORINAS
MX5256E (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 20,21-DINOREBURNAMENINE
AR217688A1 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF TRANS-2-SUBSTITUTED-5-ARYL-2,3,4,4A, 5,9B-HEXAHIDRO-1H-PIRIDO (4,3-B) -INDOL
AR218296A1 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 14-BETA-AMINO-MORPHINE
AR222844A1 (en) PROCEDURE FOR THE OBTAINING OF NEW DERIVATIVES OF N1-GLUCOFURANOSIL-6-ILO-N3-NITROSO-UREAS
MX4884E (en) PROCEDURE FOR THE PREPARATION OF THENOPYRIDINE DERIVATIVES
AR223465A1 (en) PROCEDURE FOR OBTAINING DERIVATIVES OF 5-BENCIL-2,4-DIAMINO-PIRIMIDINAS
AR221215A1 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED CHLOROACETHANILIDES
MX5454E (en) PROCEDURE FOR PREPARING DERIVATIVES OF 1,2,4-TRIAZIN-5-ONA
MX5620E (en) IMPROVED PROCEDURE FOR THE PREPARATION OF N-HYDROXY-N-PHOSPHONOMETILGLICINA
AR218943A1 (en) PROCEDURE FOR THE PREPARATION OF TIAZIN-1,3- (3,4-B) -ISOQUINOLEIN DERIVATIVES
AR220127A1 (en) PROCEDURE FOR THE PREPARATION OF D-HOMOPREGNA-4,8-DIENO-3,20-DIONAS
AR218311A1 (en) PROCEDURE FOR THE PREPARATION OF PHENOXYMETHYL-2-IMIDAZOLINE DERIVATIVES
AR213633A1 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 4-HYDRAZINOCARBONIL-AS WELL AS 4-HYDROZONOMETHYL-7-OXICORBANIL-1-FTALAZONE
MX5188E (en) PROCEDURE FOR PREPARING DERIVATIVES OF 1,2,3-TIADIAZOLIN-2-IDA
AR216684A1 (en) PROCEDURE FOR THE PREPARATION OF APOVINCAMINA